–{•¶‚ÖƒXƒLƒbƒv
Department of Molecular and Pharmacological Neuroscience, Hiroshima University Institute of Biomedical & Health Sciences

§734-0036 L“‡Œ§L“‡Žs“ì‹æ‰à‚P|‚Q|3
TEL. 082-257-5142

‹³ŽºˆõЉîCOMPANY


ƒXƒ^ƒbƒt
Žðˆä ‹K—Y
Sakai Norio, MD, PhD.
‹³Žö
ˆãŠw”ŽŽm
Œ¤‹†ƒe[ƒ}FPKCŠˆ«‰»AƒZƒƒgƒjƒ“ƒgƒ‰ƒ“ƒXƒ|[ƒ^[
“c’† –Î
Tanaka Shigeru, MD, PhD.
y‹³Žö
”ŽŽmiˆãŠwj
Œ¤‹†ƒe[ƒ}FPí“IŠˆ«‰»Œ^GPCRA_Œo޲õĶA”]‹•ŒŒ
G ˜aò
Hide Izumi, PhD.
uŽt
–òŠw”ŽŽm
Œ¤‹†ƒe[ƒ}Fƒ~ƒNƒƒOƒŠƒA
Œ´“c ‰À“Þ
Kana Harada, PhD.
•‹³
”ŽŽmiˆã–òŠwj
Œ¤‹†ƒe[ƒ}FƒZƒƒgƒjƒ“ƒgƒ‰ƒ“ƒXƒ|[ƒ^[Aƒ|ƒŠƒŠƒ“Ž_

Œ¤‹†ˆõ
”’å hŽq
Shiraki Hiroko, PhD.
”ŽŽmiˆãŠwj
Œ¤‹†ƒe[ƒ}FPí“IŠˆ«‰»Œ^GPCRA‘½”­«d‰»Ç

ˆãŒn‰ÈŠwŒ¤‹†‰È”ŽŽm‰Û’ö
“èè ‘sŽu
Narasaki Sousi, MD.
”ŽŽm‰Û’öi4”Nj
L“‡‘åŠw–ƒŒ‰È
Îˆä —F”ü
Ishii Tomomi, MD.
”ŽŽm‰Û’öi2”Nj
L“‡‘åŠw–ƒŒ‰È

MD-PhD‰Û’ö
–ìŒû éD^
Noguchi Souma
”ŽŽm‰Û’öi3”N)
‹gì Œd
Kikkawa Satoshi
”ŽŽm‰Û’öi3”Nj


ƒoƒi[ƒXƒy[ƒX

L“‡‘åŠw‘åŠw‰@@ˆãŒn‰ÈŠwŒ¤‹†‰È@
_Œo–ò—Šw

§734-0036
L“‡Œ§L“‡Žs“ì‹æ‰à‚P|‚Q|‚R

TEL 082-257-5142
FAX 082-257-5144

@